Skip to main content

Cholesterol-CHD connection: evidence for the benefit of lipoprotein modification

  • Chapter
Book cover Atherosclerosis and Cardiovascular Disease
  • 75 Accesses

Abstract

Several clinical studies using lipid-lowering diets or agents have shown that lowering total cholesterol and low density lipoprotein (LDL) -cholesterol can help prevent coronary heart disease (CHD) death and non-fatal myocardial infarction [1,2]. In addition, two recent studies have shown that elevated levels of high density lipoprotein (HDL) -cholesterol also prevent CHD events [3,4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lipid Research Clinics Program: The Lipid Research Clinics1 Coronary Primary Prevention Trial (CPPT) Results. I and II. JAMA 1984; 251: 351–374.

    Google Scholar 

  2. Canner PL, Berge KG, Wenger NK, et al: Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986; 8: 1245–1255.

    Article  PubMed  CAS  Google Scholar 

  3. Manninen V, Elo MO, Frick MH, et al: Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 1988; 260: 641–651.

    Article  PubMed  CAS  Google Scholar 

  4. Blankenhorn DH, Nessim SA, Johnson RL, et al: Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass graphs. JAMA 1987; 257: 3233–3240.

    Article  PubMed  CAS  Google Scholar 

  5. Hjermann I, Holme I, Leren P: Oslo Study Diet and Antismoking Trial. Results after 102 months. Am J of Med 1986; 80 (2A): 7–11.

    Article  CAS  Google Scholar 

  6. Carlson LA, Rosenhamer G: Reduction of mortality in the Stockholm Ischemic Heart Disease Secondary Prevention Study by combined treatment with Clofibrate and nicotinic acid. Acta Med Scand 1988; 223: 405–418.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Gotto, A.M. (1990). Cholesterol-CHD connection: evidence for the benefit of lipoprotein modification. In: Descovich, G., Gaddi, A., Magri, G., Lenzi, S. (eds) Atherosclerosis and Cardiovascular Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0731-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0731-7_1

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6814-7

  • Online ISBN: 978-94-009-0731-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics